A Randomised Study to Assess Betadine in the Groin Wound of Patients Undergoing Primary Varicose Vein Surgery
Launched by ROYAL HOBART HOSPITAL · Jul 12, 2007
Trial Information
Current as of June 12, 2025
Terminated
Keywords
ClinConnect Summary
Introduction. Varicose vein surgery is common. Worldwide, the commonest indication for this type of surgery is cosmesis. However, there are also some medical indications, including venous eczema, lipodermatosclerosis and venous ulceration. The surgery is usually straight forward and can in most instances be done as a day case. Patient and medical practitioner expectations are therefore high. Surgery in the groin is notorious for its risk of wound infection. In primary varicose vein surgery, the groin wound infection can rate can be as high as 20% 1. A more realistic figure might be approxim...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing primary saphenofemoral ligation for varicose veins (can be combined with short saphenous surgery).
- Exclusion Criteria:
- • Allergy to iodine
- • Redo groin dissections
- • Patients having multiple avulsions only or saphenopopliteal ligation only
- • Patients unable to return to outpatients for 6 weeks to undergo assessment with the wound care nurse
About Royal Hobart Hospital
Royal Hobart Hospital, located in Tasmania, Australia, is a leading healthcare institution dedicated to providing comprehensive medical services and advancing clinical research. As a prominent clinical trial sponsor, the hospital is committed to enhancing patient care through innovative research initiatives that explore new treatments and therapies. With a multidisciplinary team of experienced healthcare professionals and researchers, Royal Hobart Hospital prioritizes patient safety and ethical standards while striving to contribute valuable insights to the medical community. Its collaborative approach fosters partnerships with academic institutions and industry stakeholders, reinforcing its role as a key player in advancing healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hobart, Tasmania, Australia
Patients applied
Trial Officials
Stuart Walker, MBBS
Principal Investigator
Royal Hobart Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials